ロード中...
Pharmacological Properties of DOV 315,090, an ocinaplon metabolite
BACKGROUND: Compounds targeting the benzodiazepine binding site of the GABA(A)-R are widely prescribed for the treatment of anxiety disorders, epilepsy, and insomnia as well as for pre-anesthetic sedation and muscle relaxation. It has been hypothesized that these various pharmacological effects are...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2529273/ https://ncbi.nlm.nih.gov/pubmed/18554397 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2210-8-11 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|